Global Retirement Partners’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$67 Hold
2
– – ﹤0.01% 4819
2026
Q2
$83 Buy
+2
New +$74 ﹤0.01% 4441
2025
Q4
$1.21K Sell
40
-5
-11% -$138 ﹤0.01% 3849
2025
Q3
$1.34K Buy
+45
New +$803 ﹤0.01% 3448

Other funds holding RAPP

Global Retirement Partners's RAPP Position: Q3 2026 in Review

Global Retirement Partners held its Rapport Therapeutics (RAPP) position steady in Q3 2026 at 2 shares worth $67. The position accounts for ﹤0.01% of the portfolio, ranked #4819.

Global Retirement Partners first reported a position in RAPP in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.34K in Q3 2025. 169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.

  • Global Retirement Partners held 2 shares of Rapport Therapeutics worth $67 as of Q3 2026.
  • Global Retirement Partners left its Rapport Therapeutics share count unchanged in Q3 2026.
  • Rapport Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q3 2026, its #4819 holding.
  • Global Retirement Partners first reported a position in Rapport Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Global Retirement Partners's Rapport Therapeutics position peaked at $1.34K in Q3 2025.
  • 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.

Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.